Evidence map›Paper›PMID 34661342›Full record

ArticleEMBO reports2021

Npas4 regulates medium spiny neuron physiology and gates cocaine-induced hyperlocomotion.

Thomas Lissek, Andry Andrianarivelo, Estefani Saint-Jour, Marie-Charlotte Allichon, Hanke Gwendolyn Bauersachs, Merie Nassar, Charlotte Piette, Priit Pruunsild, Yan-Wei Tan, Benoit Forget and 5 more

Open access · hybridAbstract read
In one paragraph

Article in EMBO reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Enhancement of physiology via adaptive transcription.Pflugers Archiv : European journal of physiology · 2025
    Review
  10. Empagliflozin Mitigates PTZ-Induced Seizures in Rats: Modulating Npas4 and CREB-BDNF Signaling Pathway.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Thomas LissekInterdisciplinary Center for Neurosciences, Department of Neurobiology, Heidelberg University, Heidelberg, Germany.ORCID 0000-0003-4748-5474
Andry AndrianariveloINSERM, UMR-S 1130, Neuroscience Paris Seine, Institute of Biology Paris Seine, Paris, France.ORCID 0000-0002-6369-4201
Estefani Saint-JourINSERM, UMR-S 1130, Neuroscience Paris Seine, Institute of Biology Paris Seine, Paris, France.
Marie-Charlotte AllichonINSERM, UMR-S 1130, Neuroscience Paris Seine, Institute of Biology Paris Seine, Paris, France.
Hanke Gwendolyn BauersachsInterdisciplinary Center for Neurosciences, Department of Neurobiology, Heidelberg University, Heidelberg, Germany.
Merie NassarCenter for Interdisciplinary Research in Biology (CIRB), College de France, CNRS UMR7241, INSERM U1050, Université PSL, Paris, France.
Charlotte PietteCenter for Interdisciplinary Research in Biology (CIRB), College de France, CNRS UMR7241, INSERM U1050, Université PSL, Paris, France.
Priit PruunsildInterdisciplinary Center for Neurosciences, Department of Neurobiology, Heidelberg University, Heidelberg, Germany.ORCID 0000-0001-6823-6683
Yan-Wei TanInterdisciplinary Center for Neurosciences, Department of Neurobiology, Heidelberg University, Heidelberg, Germany.
Benoit ForgetINSERM, UMR-S 1130, Neuroscience Paris Seine, Institute of Biology Paris Seine, Paris, France.
Nicolas HeckINSERM, UMR-S 1130, Neuroscience Paris Seine, Institute of Biology Paris Seine, Paris, France.
Jocelyne CabocheINSERM, UMR-S 1130, Neuroscience Paris Seine, Institute of Biology Paris Seine, Paris, France.
Laurent VenanceCenter for Interdisciplinary Research in Biology (CIRB), College de France, CNRS UMR7241, INSERM U1050, Université PSL, Paris, France.
Peter VanhoutteINSERM, UMR-S 1130, Neuroscience Paris Seine, Institute of Biology Paris Seine, Paris, France.ORCID 0000-0001-9236-4888
Hilmar BadingInterdisciplinary Center for Neurosciences, Department of Neurobiology, Heidelberg University, Heidelberg, Germany.ORCID 0000-0003-0258-4348
Centre National de la Recherche Scientifique · FRHeidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We show here that the transcription factor Npas4 is an important regulator of medium spiny neuron spine density and electrophysiological parameters and that it determines the magnitude of cocaine-induced hyperlocomotion in mice. Npas4 is induced by synaptic stimuli that cause calcium influx, but not dopaminergic or PKA-stimulating input, in mouse medium spiny neurons and human iPSC-derived forebrain organoids. This induction is independent of ubiquitous kinase pathways such as PKA and MAPK cascades, and instead depends on calcineurin and nuclear calcium signalling. Npas4 controls a large regulon containing transcripts for synaptic molecules, such as NMDA receptors and VDCC subunits, and determines in vivo MSN spine density, firing rate, I/O gain function and paired-pulse facilitation. These functions at the molecular and cellular levels control the locomotor response to drugs of abuse, as Npas4 knockdown in the nucleus accumbens decreases hyperlocomotion in response to cocaine in male mice while leaving basal locomotor behaviour unchanged.

Indexed as

CocaineCocaine-Related DisordersAnimalsBasic Helix-Loop-Helix ProteinsDopamineMaleMiceMice, Inbred C57BLNeuronsNucleus AccumbensBasic Helix-Loop-Helix ProteinsCocaineDopamineNpas4 protein, mouseaddictioncalciumcocainelocomotionNpas4

Identifiers

PMID34661342
PMCPMC8647009
OpenAlexW3205182845

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.